Last reviewed · How we verify
NCT03965702: MicroSupport
Impact of an Assisted Fluid Management System on Microvascular Parameters
NA trial testing Use of a decision support system on the EV1000 monitoring (AFM mode) in Monitoring in 86 participants. Completed in 11 August 2022.
10 July 2022
Quick facts
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 86 |
| Start date | 13 December 2021 |
| Primary completion | 10 July 2022 |
| Estimated completion | 11 August 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Use of a decision support system on the EV1000 monitoring (AFM mode)
- Manual application of the GDFT protocol (standard of care)
Conditions studied
- Monitoring — all drugs for Monitoring →
Sponsor
Assistance Publique - Hôpitaux de Paris — full company profile →
Who can join
Adults 18 to 99, any sex, with Monitoring. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will compare a group of patients managed with a manual GDFT protocol (using the EV1000 monitoring device; Edwards Life sciences, Irvine, USA) to a group of patients managed using a novel real time clinical decision support system for goal directed fluid therapy (GDFT) guidance on microvascular parameters in patients undergoing major abdominal or orthopedic surgery.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Assisted Fluid Management and Sublingual Microvascular Flow During High-Risk Abdominal Surgery: A Randomized Controlled Trial.
Coeckelenbergh S, Entzeroth M, Van der Linden P, Flick M, et al · · 2025 · cited 13× · PMID 39116013 · DOI 10.1213/ane.0000000000007097 -
Decision support guided fluid challenges and stroke volume response during high-risk surgery: a post hoc analysis of a randomized controlled trial.
Coeckelenbergh S, Rinehart J, Desebbe O, Rogoz N, et al · · 2025 · cited 4× · PMID 39826044 · DOI 10.1007/s10877-025-01261-7
Verify or expand the search:
- PubMed search for NCT03965702
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Monitoring
Currently open trials in the same condition.
- NCT07061366 — The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study. · recruiting
- NCT06511804 — Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Pa · recruiting
- NCT06702579 — Home Monitoring in Hemophilia a · recruiting
- NCT06574867 — Evaluation of the viQtor Monitoring Solution on Surgical Wards · recruiting
- NCT03426579 — Correlation Between Sedation Depth Monitoring and Reflexes During Intravenous Anesthesia With Dexmedetomidine and Remife · recruiting
Other Assistance Publique - Hôpitaux de Paris trials
Trials by the same sponsor.
- NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
- NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
- NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03965702 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
- Last refreshed: 30 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03965702.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing